Literature DB >> 17165034

Two-stage operative strategy without local antibiotic treatment for infected hip arthroplasty: clinical and radiological outcome.

Alexander C Disch1, Georg Matziolis, Carsten Perka.   

Abstract

INTRODUCTION: Two-stage revision hip surgery with insertion of local antibiotic carriers is the therapy of choice for infected hip arthroplasty. The disadvantages are the incalculable pharmacokinetics of the antibiotic, with the danger of resistance and sensitisation. In a retrospective study, the effectiveness of a two-stage revision strategy done without local antibiotics was to be investigated. PATIENTS AND METHODS: Thirty-one patients (32 hips) after two-stage revision hip surgery for infection without local antibiotics were monitored clinically and radiologically, with a follow-up of 41.3 months.
RESULTS: Nine re-debridements in combination with a systemic antibiosis had to be conducted for eradication of the infections after explantation. Reconstruction of the majority of the hips was possible without the use of revision implants and without using large structured allografts. The re-infection rate was 6.3%, the patients achieved a Harris hip score of 75.4 (range 36.1-97.0) points at the latest follow-up, and the average difference in leg length was -0.7 (range -4.5 to + 2.5) cm.
CONCLUSION: Two-stage revision of the hip can be conducted without local antibiotic application, to achieve a comparatively efficient cure of the infection and function. This investigation underlines the significance of radical surgical debridement. The optional use of more effective antibiotic carriers may reduce the number of re-debridements in the future.

Entities:  

Mesh:

Year:  2006        PMID: 17165034     DOI: 10.1007/s00402-006-0263-x

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0936-8051            Impact factor:   3.067


  12 in total

1.  [Diagnosis and treatment of periprosthetic infections].

Authors:  M Lenz; G O Hofmann; T Mückley
Journal:  Unfallchirurg       Date:  2012-06       Impact factor: 1.000

Review 2.  Infection in total hip replacement: meta-analysis.

Authors:  Surendra Senthi; Jacob T Munro; Rocco P Pitto
Journal:  Int Orthop       Date:  2010-11-18       Impact factor: 3.075

3.  Is two-stage reimplantation effective for virulent pathogenic infection in a periprosthetic hip? A retrospective analysis.

Authors:  Yong-Cheol Yoon; Devendra Lakhotia; Jong-Keon Oh; Jun Gyu Moon; Kumar Prashant; Won Yong Shon
Journal:  World J Orthop       Date:  2015-10-18

Review 4.  [Replacement of infected knee and hip endoprostheses].

Authors:  M Militz; V Bühren
Journal:  Chirurg       Date:  2010-04       Impact factor: 0.955

Review 5.  [Periprosthetic infection].

Authors:  C Perka; N Haas
Journal:  Chirurg       Date:  2011-03       Impact factor: 0.955

6.  [Preservation of hip prosthesis with local surgical revision and creation of a fistula persistens : an option for palliative treatment of periprosthetic infection in old, polymorbid patients?].

Authors:  A H Tiemann; L Homagk; M Diefenbeck; T Mückley; G O Hofmann
Journal:  Unfallchirurg       Date:  2007-12       Impact factor: 1.000

7.  Two-stage revision total hip arthroplasty for periprosthetic infections using antibiotic-impregnated cement spacers of various types and materials.

Authors:  Katsufumi Uchiyama; Naonobu Takahira; Kensuke Fukushima; Mitsutoshi Moriya; Takeaki Yamamoto; Yojiro Minegishi; Rina Sakai; Moritoshi Itoman; Masashi Takaso
Journal:  ScientificWorldJournal       Date:  2013-12-07

Review 8.  Revision of late periprosthetic infections of total hip endoprostheses: pros and cons of different concepts.

Authors:  Bernd Fink
Journal:  Int J Med Sci       Date:  2009-09-04       Impact factor: 3.738

Review 9.  Rationale for one stage exchange of infected hip replacement using uncemented implants and antibiotic impregnated bone graft.

Authors:  Heinz Winkler
Journal:  Int J Med Sci       Date:  2009-09-04       Impact factor: 3.738

10.  Development of a Novel Model for the Assessment of Dead-Space Management in Soft Tissue.

Authors:  Rema A Oliver; Vedran Lovric; Yan Yu; Chris Christou; Sean S Aiken; John J Cooper; William R Walsh
Journal:  PLoS One       Date:  2015-08-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.